Health experts in Australia believe that around 12% of Australians will experience PTSD (post-traumatic stress disorder) at some point in their lives, and about 1.5% of the population, i.e. almost 390,000 people, currently have a PTSD diagnosis. Certain groups, like those in the defence force, military veterans, first responders, and some minority communities, are more
Read More
While pandemic travel restrictions were more commonly linked to tourism businesses, the resumption of movement in FY23 enabled allied health company Healthia (ASX: HLA) to resume moving its teams around Australia and New Zealand to rollout a range of organic growth initiatives that are now bearing fruit. Operating more than 300 allied health clinics across
Read More
For over seven years, Japan’s birth rate has been witnessing a decline. Its fertility rate has fallen below the rate required to maintain a population. Of course, the consequences are dire, ranging from a small labour force to vulnerable borders. The Japanese government has been investing in developing childcare packages to entice people into having
Read More
Pumping equipment company Waterco (ASX: WAT) has inked a deal to purchase all of the shares in water solutions company Davey Water Products from GUD Holdings Limited. The acquisition is set to cost around $64.9 million, with some adjustments as per the terms of the SSA. Waterco plans to finance this acquisition through bank loans.
Read More
In 2017, personal injury law firm Shine Lawyers (ASX: SHJ) ran two class actions against Johnson & Johnson Medical Pty Ltd and Ethicon on behalf of Aussie women who suffered devastating complications after receiving faulty vaginal mesh and tape implants (to prevent stress incontinence and support damaged tissue). It transformed into one of the largest
Read More
As supply chain challenges ease, companies are finally being able to return to profitability. Tech distributor Dicker Data (ASX: DDR) is among them. In H1 2023, the Company reported strong revenue growth with unaudited revenue locking in at $1.6 billion, an increase of 9.4% on H1 CY22. The rise in revenue can be partially credited
Read More
As diseases continue to adapt, the realm of medical diagnostics must intelligently progress to adeptly combat these changes. Timely interventions and treatments are crucial to improve patient outcomes and survival rates. There are approximately 14 medical diagnostics companies listed on the ASX, striving to pioneer the early detection of new diseases and make significant progress
Read More
An on-site death, legal disputes and global ambitions—Saferoads’s (ASX: SRH) FY23 has been eventful, to say the least. Based on its latest unaudited accounts for FY23, the road safety solutions company has survived its crash test financially. The Company generated revenue (excluding government grants) of $14.66 million, marking a 19% increase compared to FY22. EBITDA
Read More
Sure, the best perk for a shareholder would be getting a big bang for their buck. Little feels better than a major ROI, but it doesn’t hurt to give your shareholders that extra incentive to stay on board—especially if times get rough. In that spirit, gym and health club operator Viva Leisure (ASX: VVA) has
Read More
After changing its name and identity, cannabis and psychedelics provider Melodiol (ASX: ME1) has decided to sell off two of its most prominent business units, Sierra Sage Herbs and Halucenex Life Sciences to US-based Panacea Life Sciences for $7.56 million in cash and shares. Panacea Life Sciences focuses on the production, research, and distribution of
Read More
